A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells.
By Wj Li, R. Tuli, C. Okafor, A. Derfoul, K. Danielson, D. Hall, Rocky S. Tuan. Biomaterials, 2005
933 citations recorded by the source corpus.
Subfields: Biomaterials, Rheumatology, Urology
View Paper: https://www.semanticscholar.org/paper/7f8e408856844472690c7ca362d2c175537067bd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
- Seeram Ramakrishna
- Zu-wei Ma
- Jason A. Burdick
- M. Kotaki
- A. Mikos
- C. Chung
- G. Vunjak‐Novakovic
- A. Atala
In Rheumatology
In Urology
Citations in the corpus
- Engineering Complex Tissues (2006, positive): “Nanomaterials or ‘‘smart’’ materials may be more suitable for this approach.(127,128) Another approach currently being explored is the use of mesenchymal progenitor cells (MPCs).”
- Potential of Nanofiber Matrix as Tissue-Engineering Scaffolds (2005, positive): “30,31,65 cultured fibroblasts, cartilage, and bone marrow-derived mesenchymal stem cells on PLGA or PCL nanofibers.”
- Engineering cartilage tissue. (2008, methodology): “Chondrocytes Articular [32,54,57,114,139,236,237] Auricular [12,36,37,49,125] Costal [47–49,238] Nasoseptal [38,42,43,45,46] Fibroblasts [4,60,62,63] Stem cells Bone-marrow derived [74,80,82,91,103,239] Adipose-derived [65,93,95–97,99] Muscle-derived [66,67,240] Synovium-derived [68–70] Periosteum-d”